According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are โน14.24 Billion. In 2024 the company made an earning of โน429.48 Billion, an increase over its 2023 earnings that were of โน377.31 Billion. The earnings displayed on this page is the company's Pretax Income.